| Autor: |
Zarek J; The Motherisk Program, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics, Hospital for Sick Children, Toronto ON., Koren G; The Motherisk Program, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics, Hospital for Sick Children, Toronto ON. |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC [J Obstet Gynaecol Can] 2014 Jun; Vol. 36 (6), pp. 506-509. |
| DOI: |
10.1016/S1701-2163(15)30565-X |
| Abstrakt: |
Although an initial case series suggested that use of statins in pregnancy carried teratogenic risk, a recent meta-analysis of controlled observational studies has failed to corroborate this. A large number of potentially beneficial uses of statins in pregnant women have prompted a new evaluation of the risk-benefit ratio of these agents in pregnancy. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
